Provided by Tiger Trade Technology Pte. Ltd.

Sana Biotechnology, Inc.

3.91
+0.17004.55%
Post-market: 3.86-0.0500-1.28%19:54 EDT
Volume:2.93M
Turnover:11.55M
Market Cap:1.17B
PE:-5.12
High:4.10
Open:3.78
Low:3.74
Close:3.74
52wk High:6.55
52wk Low:2.61
Shares:299.00M
Float Shares:191.00M
Volume Ratio:0.91
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7636
EPS(LYR):-0.9642
ROE:-152.87%
ROA:-29.16%
PB:7.56
PE(LYR):-4.06

Loading ...

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

GlobeNewswire
·
Jul 01

Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative?

Simply Wall St.
·
Jul 01

Harbour BioMed appoints Sana Biotechnology CSO Dhavalkumar Patel as scientific advisor

Reuters
·
Jun 12

Sana Biotechnology Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jun 06

Sana Biotechnology to Present at June 2026 Investor Conferences

GlobeNewswire
·
May 28

Stanley Lifestyles Subsidiary Wins RBI Chennai Furniture Order

TIPRANKS
·
May 27

Sana Biotechnology (SANA) Gets a Buy from Morgan Stanley

TIPRANKS
·
May 18

Sana Biotechnology Raises $69 Million Through Equity Offering

TIPRANKS
·
May 16

Sana Biotechnology sells 21,607,878 shares via ATM for net proceeds of $69 million

Reuters
·
May 15

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through Its at-the-Market (Atm) Facility

THOMSON REUTERS
·
May 15

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

GlobeNewswire
·
May 15

Sana Biotechnology (SANA) Receives a Buy from Wedbush

TIPRANKS
·
May 13

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

TIPRANKS
·
May 13

Sana plans SG293 in vivo CAR-T trial in non-Hodgkin lymphoma later 2026

Reuters
·
May 13

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

GlobeNewswire
·
May 13

Bank of America Securities Keeps Their Buy Rating on Sana Biotechnology (SANA)

TIPRANKS
·
May 12

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

TIPRANKS
·
May 12

Sana Biotechnology Q1 Adj. EPS $(0.14) Beats $(0.17) Estimate

Benzinga Earnings
·
May 12

Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway

Reuters
·
May 12

BRIEF-Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17

Reuters
·
May 12